Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Additional Information (Detail)

v3.24.1
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
 12 Months Ended
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Summary Of Significant Accounting Policies [Line Items]      
Common stock, par value   $ 0.001 $ 0.001
Research and development expenses   $ 13,618,348 $ 12,034,985
Cash and cash equivalents   9,170,000 7,190,000
Allowance for doubtful accounts   0 0
Reverse stock split description we effected a reverse stock split at the ratio of 1 post-split share for every 6 pre-split shares    
Vendor [Member]      
Summary Of Significant Accounting Policies [Line Items]      
Research and development expenses   33,000 23,000
Payable balance to vendor   $ 14,000 $ 16,000
Computer Equipment [Member] | Minimum      
Summary Of Significant Accounting Policies [Line Items]      
Estimated Useful Lives   three  
Office Equipment [Member] | Maximum      
Summary Of Significant Accounting Policies [Line Items]      
Estimated Useful Lives   five  
Customer Concentration Risk | Sales Revenue      
Summary Of Significant Accounting Policies [Line Items]      
Concentration risk, percentage   100.00% 100.00%